Annual FCF
-$22.36 M
+$2.49 M+10.01%
31 December 2023
Summary:
Evogene annual free cash flow is currently -$22.36 million, with the most recent change of +$2.49 million (+10.01%) on 31 December 2023. During the last 3 years, it has fallen by -$2.17 million (-10.72%). EVGN annual FCF is now -1275.28% below its all-time high of -$1.63 million, reached on 31 December 2011.EVGN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$5.06 M
+$426.00 K+7.77%
30 September 2024
Summary:
Evogene quarterly free cash flow is currently -$5.06 million, with the most recent change of +$426.00 thousand (+7.77%) on 30 September 2024. Over the past year, it has dropped by -$527.00 thousand (-11.63%). EVGN quarterly FCF is now -552.90% below its all-time high of -$775.00 thousand, reached on 31 December 2013.EVGN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$20.81 M
-$527.00 K-2.60%
30 September 2024
Summary:
Evogene TTM free cash flow is currently -$20.81 million, with the most recent change of -$527.00 thousand (-2.60%) on 30 September 2024. Over the past year, it has dropped by -$2.00 million (-10.64%). EVGN TTM FCF is now -608.72% below its all-time high of -$2.94 million, reached on 31 March 2013.EVGN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVGN Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.0% | -11.6% | -10.6% |
| 3 y3 years | -10.7% | +15.5% | +14.0% |
| 5 y5 years | -44.0% | -28.1% | -25.4% |
EVGN Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -10.7% | +12.5% | -106.0% | +39.3% | -10.6% | +32.3% |
| 5 y | 5 years | -44.0% | +12.5% | -106.0% | +39.3% | -25.4% | +32.3% |
| alltime | all time | -1275.3% | +12.5% | -552.9% | +39.3% | -608.7% | +32.3% |
Evogene Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.06 M(-7.8%) | -$20.81 M(+2.6%) |
| June 2024 | - | -$5.49 M(+29.1%) | -$20.28 M(+1.4%) |
| Mar 2024 | - | -$4.25 M(-29.3%) | -$20.01 M(-10.5%) |
| Dec 2023 | -$22.36 M(-10.0%) | -$6.01 M(+32.6%) | -$22.36 M(+18.9%) |
| Sept 2023 | - | -$4.53 M(-13.1%) | -$18.81 M(-12.7%) |
| June 2023 | - | -$5.21 M(-21.0%) | -$21.55 M(-7.5%) |
| Mar 2023 | - | -$6.60 M(+168.9%) | -$23.30 M(-6.2%) |
| Dec 2022 | -$24.85 M(-2.8%) | -$2.46 M(-66.3%) | -$24.85 M(-19.2%) |
| Sept 2022 | - | -$7.28 M(+4.6%) | -$30.73 M(+4.4%) |
| June 2022 | - | -$6.96 M(-14.6%) | -$29.44 M(+2.1%) |
| Mar 2022 | - | -$8.15 M(-2.3%) | -$28.84 M(+12.8%) |
| Dec 2021 | -$25.56 M(+26.6%) | -$8.34 M(+39.3%) | -$25.56 M(+5.7%) |
| Sept 2021 | - | -$5.99 M(-5.8%) | -$24.20 M(+6.3%) |
| June 2021 | - | -$6.36 M(+30.5%) | -$22.76 M(+17.9%) |
| Mar 2021 | - | -$4.87 M(-30.1%) | -$19.30 M(-4.4%) |
| Dec 2020 | -$20.20 M(+8.8%) | -$6.97 M(+53.1%) | -$20.20 M(+10.6%) |
| Sept 2020 | - | -$4.56 M(+57.2%) | -$18.27 M(+3.4%) |
| June 2020 | - | -$2.90 M(-49.7%) | -$17.66 M(-6.5%) |
| Mar 2020 | - | -$5.77 M(+14.4%) | -$18.89 M(+1.8%) |
| Dec 2019 | -$18.57 M(+19.5%) | -$5.04 M(+27.7%) | -$18.57 M(+11.9%) |
| Sept 2019 | - | -$3.95 M(-4.4%) | -$16.59 M(-0.9%) |
| June 2019 | - | -$4.13 M(-24.1%) | -$16.73 M(+4.6%) |
| Mar 2019 | - | -$5.44 M(+77.5%) | -$16.00 M(+3.0%) |
| Dec 2018 | -$15.54 M | -$3.06 M(-25.2%) | -$15.54 M(-4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$4.10 M(+20.7%) | -$16.18 M(+3.4%) |
| June 2018 | - | -$3.39 M(-31.9%) | -$15.65 M(-4.8%) |
| Mar 2018 | - | -$4.98 M(+34.1%) | -$16.44 M(-0.5%) |
| Dec 2017 | -$16.52 M(+32.1%) | -$3.71 M(+4.2%) | -$16.52 M(-3.6%) |
| Sept 2017 | - | -$3.56 M(-14.7%) | -$17.13 M(+1.1%) |
| June 2017 | - | -$4.18 M(-17.5%) | -$16.95 M(+12.0%) |
| Mar 2017 | - | -$5.06 M(+17.0%) | -$15.13 M(+21.0%) |
| Dec 2016 | -$12.50 M(-13.3%) | -$4.33 M(+28.3%) | -$12.50 M(-5.3%) |
| Sept 2016 | - | -$3.38 M(+43.0%) | -$13.20 M(+1.6%) |
| June 2016 | - | -$2.36 M(-3.2%) | -$12.99 M(-5.4%) |
| Mar 2016 | - | -$2.44 M(-51.5%) | -$13.72 M(-4.8%) |
| Dec 2015 | -$14.41 M(+15.7%) | -$5.03 M(+59.0%) | -$14.41 M(+18.0%) |
| Sept 2015 | - | -$3.16 M(+2.2%) | -$12.22 M(-2.1%) |
| June 2015 | - | -$3.10 M(-1.0%) | -$12.48 M(+3.5%) |
| Mar 2015 | - | -$3.13 M(+10.3%) | -$12.06 M(-3.2%) |
| Dec 2014 | -$12.46 M(+81.0%) | -$2.83 M(-17.4%) | -$12.46 M(+19.8%) |
| Sept 2014 | - | -$3.43 M(+28.4%) | -$10.40 M(+15.0%) |
| June 2014 | - | -$2.67 M(-24.3%) | -$9.05 M(+21.0%) |
| Mar 2014 | - | -$3.53 M(+355.0%) | -$7.47 M(+8.6%) |
| Dec 2013 | -$6.88 M(+41.9%) | -$775.00 K(-62.7%) | -$6.88 M(+12.7%) |
| Sept 2013 | - | -$2.08 M(+89.2%) | -$6.11 M(+51.5%) |
| June 2013 | - | -$1.10 M(-62.6%) | -$4.03 M(+37.4%) |
| Mar 2013 | - | -$2.94 M | -$2.94 M |
| Dec 2012 | -$4.85 M(+198.3%) | - | - |
| Dec 2011 | -$1.63 M | - | - |
FAQ
- What is Evogene annual free cash flow?
- What is the all time high annual FCF for Evogene?
- What is Evogene annual FCF year-on-year change?
- What is Evogene quarterly free cash flow?
- What is the all time high quarterly FCF for Evogene?
- What is Evogene quarterly FCF year-on-year change?
- What is Evogene TTM free cash flow?
- What is the all time high TTM FCF for Evogene?
- What is Evogene TTM FCF year-on-year change?
What is Evogene annual free cash flow?
The current annual FCF of EVGN is -$22.36 M
What is the all time high annual FCF for Evogene?
Evogene all-time high annual free cash flow is -$1.63 M
What is Evogene annual FCF year-on-year change?
Over the past year, EVGN annual free cash flow has changed by +$2.49 M (+10.01%)
What is Evogene quarterly free cash flow?
The current quarterly FCF of EVGN is -$5.06 M
What is the all time high quarterly FCF for Evogene?
Evogene all-time high quarterly free cash flow is -$775.00 K
What is Evogene quarterly FCF year-on-year change?
Over the past year, EVGN quarterly free cash flow has changed by -$527.00 K (-11.63%)
What is Evogene TTM free cash flow?
The current TTM FCF of EVGN is -$20.81 M
What is the all time high TTM FCF for Evogene?
Evogene all-time high TTM free cash flow is -$2.94 M
What is Evogene TTM FCF year-on-year change?
Over the past year, EVGN TTM free cash flow has changed by -$2.00 M (-10.64%)